On December 26, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Pharmaceutical Co., Ltd., received the “Notice of Acceptance” issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. The application for marketing registration of a new veterinary drug of the HDM7006 project prepotide injection was accepted. The declared indication was weight management for adult obese cats.

Zhitongcaijing · 2d ago
On December 26, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Huadong Pharmaceutical Co., Ltd., received the “Notice of Acceptance” issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China. The application for marketing registration of a new veterinary drug of the HDM7006 project prepotide injection was accepted. The declared indication was weight management for adult obese cats.